Canagliflozin vs Panitumumab

## Canagliflozin vs Panitumumab: Overview

This comparison examines the pharmacological differences between **Canagliflozin** and **Panitumumab**.

## Mechanism of Action

**Canagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption and lowering blood glucose.

## Pharmacokinetics

**Half-life**: Canagliflozin — 10.6 hours; Panitumumab — N/A.

## Chemical Properties

**Molecular Formula**: Canagliflozin — C24H25FO5S; Panitumumab — N/A.

**Molecular Weight**: Canagliflozin — 444.5170 g/mol; Panitumumab — N/A.

**Type**: Canagliflozin — Small molecule; Panitumumab — Antibody.